IQOS 3 is approved for sale in the US as FDA finds 'no new concerns'

The US Food and Drug Administration (FDA) has issued a marketing order authorising the sale of Philip Morris International (PMI)’s IQOS 3 holder and charger

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Corporate Email*

Company Name*

Name*

Department*

Industry*

Work Telephone*

How did you hear about us?*

Tell us what you're interested in*

Name

This field is for validation purposes and should be left unchanged.

I'm already a subscriber

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

LATEST ALERTS

IQOS 3 is approved for sale in the US as FDA finds ‘no new concerns’

TobaccoIntelligence

Our Key Benefits

Sign up to our newsletter

LATEST ALERTS

Want the full analysis? Let's talk

TobaccoIntelligence

Our Key Benefits

Want the full analysis? Let's talk

Sign up to our newsletter

Start your FREE trial